Why the US center for Medicare and Medicaid services should not extend reimbursement indications for carotid artery angioplasty/stenting

Simple item page
dc.contributor.authorAbbott, A.
dc.contributor.authorKleinig, T.
dc.date.issued2012
dc.description.statementofresponsibilityAnne L. Abbott...Timothy J. Kleinig...et al.
dc.identifier.citationAngiology, 2012; 63(8):639-644
dc.identifier.doi10.1177/0003319711436076
dc.identifier.issn0003-3197
dc.identifier.issn1940-1574
dc.identifier.orcidKleinig, T. [0000-0003-4430-3276]
dc.identifier.urihttp://hdl.handle.net/2440/78596
dc.language.isoen
dc.publisherWestminster Publ Inc
dc.rights© The Author(s) 2012
dc.source.urihttps://doi.org/10.1177/0003319711436076
dc.subjectHumans
dc.subjectCarotid Artery Diseases
dc.subjectStents
dc.subjectMedicaid
dc.subjectMedicare
dc.subjectInsurance, Health, Reimbursement
dc.subjectUnited States
dc.subjectStroke
dc.subjectAngioplasty, Balloon, Coronary
dc.subjectCenters for Medicare and Medicaid Services, U.S.
dc.titleWhy the US center for Medicare and Medicaid services should not extend reimbursement indications for carotid artery angioplasty/stenting
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Anatomical Sciences publications